After 3 consecutive anti-VEGF treatments, the level of VEGF in BRVO of ischemic group and non-ischemic group decreased significantly, macular edema could disappear quickly, and visual acuity could be recovered quickly, which may be the reason for the same visual acuity prognosis in both groups. This evidence concerns the gene VEGFA and macular retinal edema.